# A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease

> **NCT00989573** · PHASE2,PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 191 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** OPC-6535
- **DRUG:** OPC-6535

## Key facts

- **NCT ID:** NCT00989573
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2021-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00989573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00989573, "A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00989573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*